Renalytix Plc Adr (RNLX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt RNLX? Forum Prognose

Finanzdaten der Renalytix Plc Adr-Aktie (RNLX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate
Revenues	24.54% 0.535	0.709	0.459
Cost Of Revenue	25.21% 0.601	0.48	0.502
Gross Profit	128.82% -0.066	0.229	-0.043
Operating Expenses	26.87% 6.487	8.87	8.846
Benefits Costs and Expenses	9.92% 8.278	9.19	10.61
Costs And Expenses	9.92% 8.278	9.19	10.61
Operating Income/Loss	24.16% -6.553	-8.641	-8.889
Income/Loss From Equity Method Investments	-	-	-
Income/Loss From Continuing Operations Before Tax	8.70% -7.743	-8.481	-10.15
Income Tax Expense/Benefit	100.00% -	0.004	-
Income/Loss From Continuing Operations After Tax	8.74% -7.743	-8.485	-10.15
Net Income/Loss	8.74% -7.743	-8.485	-10.15
Preferred Stock Dividends And Other Adjustments	-	-	-
Attributable To Noncontrolling Interest	-	-	-
Basic Average Shares	0.40% 97.65	97.27	94.77
Diluted Average Shares	0.40% 97.65	97.27	94.77
Basic Earnings Per Share	11.11% -0.08	-0.09	-0.11
Diluted Earnings Per Share	11.11% -0.08	-0.09	-0.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-

OMCL

$49.80

2.66%

EVH

$23.57

0.90%

BTSG

$17.63

4.88%

WAY

$29.01

1.26%

RCM

$14.27

0.07%

TEM

$44.50

10.10%